Mukai, S.; Sakamoto, N.; Kakinoki, H.; Shibuya, T.; Moriya, R.; Nishihara, K.; Noguchi, M.; Shin, T.; Fujimoto, N.; Igawa, T.;
et al. Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis. J. Clin. Med. 2022, 11, 3538.
https://doi.org/10.3390/jcm11123538
AMA Style
Mukai S, Sakamoto N, Kakinoki H, Shibuya T, Moriya R, Nishihara K, Noguchi M, Shin T, Fujimoto N, Igawa T,
et al. Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis. Journal of Clinical Medicine. 2022; 11(12):3538.
https://doi.org/10.3390/jcm11123538
Chicago/Turabian Style
Mukai, Shoichiro, Naotaka Sakamoto, Hiroaki Kakinoki, Tadamasa Shibuya, Ryosuke Moriya, Kiyoaki Nishihara, Mitsuru Noguchi, Toshitaka Shin, Naohiro Fujimoto, Tsukasa Igawa,
and et al. 2022. "Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis" Journal of Clinical Medicine 11, no. 12: 3538.
https://doi.org/10.3390/jcm11123538
APA Style
Mukai, S., Sakamoto, N., Kakinoki, H., Shibuya, T., Moriya, R., Nishihara, K., Noguchi, M., Shin, T., Fujimoto, N., Igawa, T., Ishii, T., Haga, N., Enokida, H., Eto, M., Kamba, T., Sakai, H., Saito, S., Terada, N., & Kamoto, T.
(2022). Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis. Journal of Clinical Medicine, 11(12), 3538.
https://doi.org/10.3390/jcm11123538
